82560-12-1Relevant articles and documents
Synthesis, structural characterization, and theoretical studies of new pyrazole (E)-2-{[(5-(tert-butyl)-1H-pyrazol-3-yl)imino]methyl}phenol and (E)-2-{[(1-(4-bromophenyl)-3-(tert-butyl)-1H-pyrazol-5-yl]imino]methyl}phenol
Cuenú, Fernando,Restrepo-Acevedo, Andrés,Isabel-Murillo, María,Eduard Torres, John,Moreno-Fuquen, Rodolfo,Abonia, Rodrigo,Kennedy, Alan R.,Tenorio, Juan Carlos,Lehmann, Christian W.
, p. 59 - 71 (2019)
In this paper, theoretical and experimental studies of two new Schiff bases were performed. The (E)-2-{[(5-(tert-butyl)-1H-pyrazol-3-yl)imino]methyl}phenol (3) and (E)-2-{[(1-(4-bromophenyl)-3-(tert-butyl)-1H-pyrazol-5-yl]imino]methyl}phenol (5)compounds were characterized by spectroscopic techniques, (i.e. MS, NMR, FT–IR, UV–vis, and single-crystal X–ray diffraction). The molecular geometry of both compounds in the ground state, vibrational frequencies, and chemical shift were calculated by using the functional density theory method, with B3LYP as functional and 6-31G** as basis set, using the GAUSSIAN 09 program package. With the VEDA 4 program, the vibrational frequencies were allocated in terms of potential energy distribution (PED). In this paper, theoretical and experimental studies of two new Schiff bases were performed. The (E)-2-{[(5-(tert-butyl)-1H-pyrazol-3-yl)imino]methyl}phenol (3) and (E)-2-{[(1-(4-bromophenyl)-3-(tert-butyl)-1H-pyrazol-5-yl]imino]methyl}phenol (5) compounds were characterized by spectroscopic techniques, (i.e. MS, NMR, FT-IR, UV–vis, and single-crystal X-ray diffraction). The molecular geometry of both compounds in the ground state, vibrational frequencies, and chemical shift were calculated by using the functional density theory method, with B3LYP as functional and 6-31G** as basis set, using the GAUSSIAN 09 program package. With the VEDA 4 program, the vibrational frequencies were allocated in terms of potential energy distribution (PED). Molecular stabilities were determined in terms of softness and hardness, and the values were determined from the energies of HOMO and LUMO orbitals. Remarkably, good agreements between the calculated IR, NMR and UV–vis spectra in comparison to those experimental ones, were found.
Identification of TRD-35 as Potent and Selective DRAK2 Inhibitor
Ali, Imran,Park, Sangjun,Jung, Myoung Eun,Lee, Nari,Bibi, Maimoona,Chae, Chong Hak,Yang, Kyung-Min,Kim, Seong-Jin,Choi, Gildon,Lee, Kwangho
supporting information, p. 567 - 569 (2020/03/23)
-
Novel pyrimidine derivatives, preparation method thereof, and pharmaceutical composition for use in preventing or treating DRAK relating diseases containing the same as an active ingredient
-
Paragraph 0116; 0160-0162, (2017/08/02)
The present invention relates to a novel pyrimidine derivative, a production method thereof, and a pharmaceutical composition for preventing or treating death-associated protein related apoptosis inducing protein kinase (DRAK)-associated diseases containing the same as an active ingredient. According to the present invention, the novel pyrimidine derivative, an optical isomer thereof, or a pharmaceutically acceptable salt thereof exhibits effective inhibitory activities on DRAK, and thus can be useful for treating diseases caused by DRAK such as cancer and tumor.COPYRIGHT KIPO 2017